摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-甲基伞形酮基-Alpha-D-吡喃甘露糖苷 | 28541-83-5

中文名称
4-甲基伞形酮基-Alpha-D-吡喃甘露糖苷
中文别名
4-甲基伞形酮基-Α-D-吡喃甘露糖苷;4-甲基伞形酮-a-D-甘露糖苷;4-甲基伞形酮基-α-D-吡喃甘露糖苷;4-甲基伞形酮酰-α-D-甘露糖苷
英文名称
4-methylumbellifer-7-yl α-D-mannopyranoside
英文别名
4-methylumbelliferyl α-D-mannopyranoside;4-methylumbelliferyl-α-D-mannopyranoside;methylumbelliferyl-α-D-mannopyranoside;methylumbelliferyl α-D-mannoside;MUM;4-methylumbellifer-7-yl-α-D-mannopyranoside;4-METHYLUMBELLIFERYL-alpha-D-MANNOPYRANOSIDE;4-methyl-7-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
4-甲基伞形酮基-Alpha-D-吡喃甘露糖苷化学式
CAS
28541-83-5
化学式
C16H18O8
mdl
——
分子量
338.314
InChiKey
YUDPTGPSBJVHCN-VMMWWAARSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    190 °C
  • 沸点:
    626.9±55.0 °C(Predicted)
  • 密度:
    1.522±0.06 g/cm3(Predicted)
  • 溶解度:
    在吡啶中可溶20 mg/mL,澄清,淡黄色

计算性质

  • 辛醇/水分配系数(LogP):
    -0.8
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    126
  • 氢给体数:
    4
  • 氢受体数:
    8

安全信息

  • 安全说明:
    S24/25
  • WGK Germany:
    3
  • 海关编码:
    29400090

SDS

SDS:7f237c115651796baeb7715fb6b846d9
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Profiling of Glycosidase Activities Using Coumarin-Conjugated Glycoside Cocktails
    摘要:
    Glycosidases are a large subgroup of carbohydrate-processing enzymes that hydrolytically cleave the glycosidic bond. Glycans formed by the action of glycosidases are involved in various biological processes. Genetic abnormalities in glycosidases are associated with inherited diseases. Thus, characterization of the catalytic activities of glycosidases is of great importance. Herein, we describe a simple and rapid approach for determining glycosidase activity profiles using coumarin-conjugated glycoside cocktails.
    DOI:
    10.1021/ol062889f
点击查看最新优质反应信息

文献信息

  • TARGETED NANOPREPARATION OF MANNOSE, AND PREPARATION THEREFOR AND APPLICATION THEREOF
    申请人:CHENGDU RIBOCURE PHARMATECH COMPANY LIMITED
    公开号:US20210196832A1
    公开(公告)日:2021-07-01
    The present invention relates to the field of pharmaceutical preparations, in particular, to a mannose modified targeting nano-preparations, a composition for preparing nano-preparations, a targeting element, a targeting vector, a prepared targeting drug and a preparation method and the application thereof. The described nano-preparations with targeting function is composed of the targeting ligand mannose and its derivatives, nano-preparations and main drug components, and the described targeting material is linked with the spacer material, and then linked with the nano-preparations material to prepare the nano-preparations. The targeting nano-preparations in the present invention has good targetability of mannose receptor, can effectively bond with mannose receptor on target cell. Moreover, the preparation method has universality, can be used for synthesizing a variety of targeting nano-preparations, and is conducive to purification and characterization.
    本发明涉及制药制剂领域,具体地说,涉及一种甘露糖修饰靶向纳米制剂,用于制备纳米制剂的组合物,靶向元素,靶向载体,制备的靶向药物以及其制备方法和应用。所述具有靶向功能的纳米制剂由靶向配体甘露糖及其衍生物、纳米制剂和主要药物成分组成,所述靶向材料与间隔材料连接,然后与纳米制剂材料连接以制备纳米制剂。本发明的靶向纳米制剂具有良好的甘露糖受体靶向性,能够有效地与靶细胞上的甘露糖受体结合。此外,制备方法具有普适性,可用于合成各种靶向纳米制剂,并有利于纯化和表征。
  • An Improved Helferich Method for the α/β-Stereoselective Synthesis of 4-Methylumbelliferyl Glycosides for the Detection of Microorganisms
    作者:Xianhu Wei、Yanxia Ma、Qingping Wu、Jumei Zhang、Zhihe Cai、Mianfei Lu
    DOI:10.3390/molecules201219789
    日期:——
    An improved Helferich method is presented. It involves the glycosylation of 4-methyl-umbelliferone with glycosyl acetates in the presence of boron trifluoride etherate combined with triethylamine, pyridine, or 4-dimethylaminopyridine under mild conditions, followed by deprotection to give fluorogenic 4-methylumbelliferyl glycoside substrates. Due to the use of base, the glycosylation reaction proceeds more easily, is uncommonly α- or β-stereoselective, and affords the corresponding products in moderate to excellent yields (51%–94%) under appropriate conditions.
    提出了一种改进的Helferich方法,涉及在温和条件下,将4-甲基伞形酮与糖基乙酸酯在三氟化硼乙醷存在下与三乙胺、吡啶或4-二甲氨基吡啶联合使用进行糖基化,随后脱保护得到荧光4-甲基伞形酰基糖苷底物。由于使用碱基,糖基化反应更容易进行,具有不寻常的α或β立体选择性,并在适当条件下获得中等至优异的产率(51%至94%)。
  • Glycosyl Coumarin Carbonic Anhydrase IX and XII Inhibitors Strongly Attenuate the Growth of Primary Breast Tumors
    作者:Nadia Touisni、Alfonso Maresca、Paul C. McDonald、Yuanmei Lou、Andrea Scozzafava、Shoukat Dedhar、Jean-Yves Winum、Claudiu T. Supuran
    DOI:10.1021/jm200983e
    日期:2011.12.22
    inhibition of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1). These coumarins were very weak or ineffective as inhibitors of the housekeeping, offtarget isoforms CA I and II, but some of them inhibited tumor-associated CA IX and XII in the low nanomolar range. They also significantly inhibited the growth of primary tumors by the highly aggressive 4T1 syngeneic mouse mammary tumor cells at 30 mg/kg, constituting
    合成了一系列结合了各种糖基部分的7-取代香豆素,并研究了其对锌酶碳酸酐酶的抑制作用(CA,EC 4.2.1.1)。这些香豆素作为管家抑制剂,脱靶亚型CA I和II非常弱或无效,但其中一些在低纳摩尔范围内抑制与肿瘤相关的CA IX和XII。它们还以30 mg / kg的高侵袭性4T1同系小鼠乳腺肿瘤细胞显着抑制了原发性肿瘤的生长,构成了开发概念上新颖的抗癌药物的有趣候选物。由于CA IX在低氧性肿瘤中过表达,并且在正常组织中的表达非常有限,因此此类化合物可用于治疗对经典化学疗法和放射疗法无反应的癌症。
  • Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same
    申请人:Innovation Hammer, LLC
    公开号:US20140331555A1
    公开(公告)日:2014-11-13
    Methods for promoting plant growth based on novel photosafening treatment regimes with glycopyranosides including glycopyranosylglycopyranosides, and aryl-a-D-glycopyranosides, and more specifically, with one or more compounds comprising terminal mannosyl-triose, optionally in the presence of light enhanced by one or more light reflecting and/or refracting members such as silicon-based substrates. Furthermore, chemical synthesis processes for the above compounds are disclosed for general application to plants. Silicate microbeads of the like are distributed over the ground or substrate in which roots of a plant are supported and planted, beneath and around a plant in a manner that light is refracted or reflected toward the phylloplane.
    基于新型光保护处理方案促进植物生长的方法,包括甘露聚糖苷类化合物,如甘露聚糖苷和芳基-a-D-甘露聚糖苷,更具体地,使用含有端基甘露三糖的一个或多个化合物,可选地在存在硅基基底等一个或多个反射和/或折射光的成员的情况下增强光线。此外,还公开了上述化合物的化学合成过程,以供普遍应用于植物。类似的硅酸盐微珠分布在植物的根部支撑和种植的地面或基质上,在植物的下方和周围,使光线以折射或反射的方式朝向叶面。
  • [EN] CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY<br/>[FR] INHIBITEURS D'ANHYDRASE CARBONIQUE PRÉSENTANT UNE ACTIVITÉ ANTIMÉTASTATIQUE
    申请人:METASIGNAL THERAPEUTICS INC
    公开号:WO2012070024A1
    公开(公告)日:2012-05-31
    Compositions for the treatment of cancer comprising coumarin and thiocoumarin derivatives of Formulas I- XII are disclosed. Said derivatives preferentially inhibit carbonic anhydrase IX and XII (which are associated with hypoxic and metastatic tumours) over inhibiting carbonic anhydrase I and II activity. The compositions therefore are suited for treatment of hypoxic or metastatic cancers due to this selective mechanism of action.
    本发明揭示了用于治疗癌症的组合物,包括公开的具有I-XII式的香豆素和硫代香豆素衍生物。所述衍生物优先抑制与低氧和转移性肿瘤相关的碳酸酐酶IX和XII,而不是抑制碳酸酐酶I和II的活性。因此,这些组合物由于这种选择性作用机制而适用于治疗低氧或转移性癌症。
查看更多